Company
Grit Biotechnology
Grit Biotechnology has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| GT101 | Phase 2 | Recurrent or Metastatic Cervical Cancer |
Latest
No recent events.
Follow Grit Biotechnology on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.